Aims: To evaluate the diagnostic accuracy of Claude-3, a large language model, in detecting pathological features and diagnosing retinitis pigmentosa and cone-rod dystrophy using pattern electroretinography data.
Methods: A subset of pattern electroretinography measurements from healthy individuals, patients with retinitis pigmentosa and cone-rod dystrophy was randomly selected from the PERG-IOBA dataset. The pattern electroretinography and clinical data, including age, gender, visual acuities, were provided to Claude-3 for analysis and diagnostic predictions. The model’s accuracy was assessed in two scenarios: “first choice,” evaluating the accuracy of the primary differential diagnosis and “top 3,” evaluating whether the correct diagnosis was included within the top three differential diagnoses.
Results: A total of 46 subjects were included in the study: 20 healthy individuals, 13 patients with retinitis pigmentosa, 13 patients with cone-rod dystrophy. Claude-3 achieved 100% accuracy in detecting the presence or absence of pathology. In the “first choice” scenario, the model demonstrated moderate accuracy in diagnosing retinitis pigmentosa (61.5%) and cone-rod dystrophy (53.8%). However, in the “top 3” scenario, the model’s performance significantly improved, with accuracies of 92.3% for retinitis pigmentosa and 76.9% for cone-rod dystrophy.
Conclusion: This is the first study to demonstrate the potential of large language models, specifically Claude-3, in analyzing pattern electroretinography data to diagnose retinal disorders. Despite some limitations, the model’s high accuracy in detecting pathologies and distinguishing between specific diseases highlights the potential of large language models in ocular electrophysiology. Future research should focus on integrating multimodal data, and conducting comparative analyses with human experts.
Retinitis pigmentosa cone rod dystrophy pattern electroretinography large language models
Ethics Committee Approval: Since the PERG IOBA dataset from the PhysioNet database was used in this study, ethical approval is not required. The terms of use of the database have been adhered to. Informed Consent: Because the study was designed retrospectively, no written informed consent form was obtained from patients. Referee Evaluation Process: Externally peer-reviewed. Conflict of Interest Statement: The authors have no conflicts of interest to declare. Financial Disclosure: The authors declared that this study has received no financial support. Author Contributions: All of the authors declare that they have all participated in the design, execution, and analysis of the paper, and that they have approved the final version. Acknowledgement: Our research’s data was presented in ‘15th Medical Informatics Congress’ as ‘Oral Presentation’ on May 30, 2024.
Birincil Dil | İngilizce |
---|---|
Konular | Göz Hastalıkları |
Bölüm | Orijinal Makale |
Yazarlar | |
Yayımlanma Tarihi | 27 Eylül 2024 |
Gönderilme Tarihi | 28 Haziran 2024 |
Kabul Tarihi | 30 Ağustos 2024 |
Yayımlandığı Sayı | Yıl 2024 |
Üniversitelerarası Kurul (ÜAK) Eşdeğerliği: Ulakbim TR Dizin'de olan dergilerde yayımlanan makale [10 PUAN] ve 1a, b, c hariç uluslararası indekslerde (1d) olan dergilerde yayımlanan makale [5 PUAN]
Dahil olduğumuz İndeksler (Dizinler) ve Platformlar sayfanın en altındadır.
Not: Dergimiz WOS indeksli değildir ve bu nedenle Q olarak sınıflandırılmamıştır.
Yüksek Öğretim Kurumu (YÖK) kriterlerine göre yağmacı/şüpheli dergiler hakkındaki kararları ile yazar aydınlatma metni ve dergi ücretlendirme politikasını tarayıcınızdan indirebilirsiniz. https://dergipark.org.tr/tr/journal/2316/file/4905/show
Dergi Dizin ve Platformları
Dizinler; ULAKBİM TR Dizin, Index Copernicus, ICI World of Journals, DOAJ, Directory of Research Journals Indexing (DRJI), General Impact Factor, ASOS Index, WorldCat (OCLC), MIAR, EuroPub, OpenAIRE, Türkiye Citation Index, Türk Medline Index, InfoBase Index, Scilit, vs.
Platformlar; Google Scholar, CrossRef (DOI), ResearchBib, Open Access, COPE, ICMJE, NCBI, ORCID, Creative Commons vs.